5Mar2019 The Biotech Industry Can Help Address the Opioid Crisis. But We Aren’t Doing Enough /Alex Harding/0/All, Drugs05 Mar 2019 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.